BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21102426)

  • 1. Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1.
    Zhang L; Jiang Y; Zheng Y; Zeng Y; Yang Z; Huang G; Liu D; Gao M; Shen X; Wu G; Yan X; He F
    Leukemia; 2011 Feb; 25(2):331-40. PubMed ID: 21102426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells.
    Zhang L; Gao H; Chen L; Wu B; Zheng Y; Liao R; Jiang Y; He F
    Cancer Lett; 2008 Sep; 269(1):26-36. PubMed ID: 18534744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin.
    Parameswaran R; Yu M; Lyu MA; Lim M; Rosenblum MG; Groffen J; Heisterkamp N
    Leukemia; 2012 Aug; 26(8):1786-96. PubMed ID: 22373785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor.
    Zhou XZ; Lu KP
    Cell; 2001 Nov; 107(3):347-59. PubMed ID: 11701125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-terminal amino acids 290-328 of LPTS/PinX1 confer telomerase inhibition.
    Chen G; Da L; Xu Y; Xu M; Song L; Li T; Zhao M
    Biochem Biophys Res Commun; 2010 Aug; 398(4):683-9. PubMed ID: 20620128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: implications for Burkitt's lymphoma.
    Ogden CA; Pound JD; Batth BK; Owens S; Johannessen I; Wood K; Gregory CD
    J Immunol; 2005 Mar; 174(5):3015-23. PubMed ID: 15728515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cell activating factor (BAFF) gene promoter activity depends upon co-activator, p300.
    Moon EY; Park H
    Immunobiology; 2007; 212(8):637-45. PubMed ID: 17869641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
    Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
    Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating B cell activating factor (BAFF) into the membrane of rabies virus (RABV) particles improves the speed and magnitude of vaccine-induced antibody responses.
    Plummer JR; McGettigan JP
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007800. PubMed ID: 31725816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bioassay for B-cell activating factor (BAFF) based on expression of a BAFF-receptor ectodomain-tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor-2 endodomain fusion receptor in human rhabdomyosarcoma cells.
    McClements M; Williams S; Ball C; Bristow A; Wadhwa M; Meager A
    J Immunol Methods; 2008 Aug; 337(1):63-70. PubMed ID: 18625509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomerase inhibitor PinX1 provides a link between TRF1 and telomerase to prevent telomere elongation.
    Soohoo CY; Shi R; Lee TH; Huang P; Lu KP; Zhou XZ
    J Biol Chem; 2011 Feb; 286(5):3894-906. PubMed ID: 21119197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The telomerase inhibitor PinX1 is a major haploinsufficient tumor suppressor essential for chromosome stability in mice.
    Zhou XZ; Huang P; Shi R; Lee TH; Lu G; Zhang Z; Bronson R; Lu KP
    J Clin Invest; 2011 Apr; 121(4):1266-82. PubMed ID: 21436583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
    Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS
    PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention.
    Baichuan L; Cao S; Liu Y
    Recent Pat Anticancer Drug Discov; 2015; 10(2):170-5. PubMed ID: 25479038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of BAFF on B cell precursor acute lymphoblastic leukemia and Burkitt lymphoma.
    Onda K; Iijima K; Katagiri YU; Okita H; Saito M; Shimizu T; Kiyokawa N
    Int J Hematol; 2010 Jun; 91(5):808-19. PubMed ID: 20428981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptor 4-mediated cAMP production up-regulates B-cell activating factor expression in Raw264.7 macrophages.
    Moon EY; Lee YS; Choi WS; Lee MH
    Exp Cell Res; 2011 Oct; 317(17):2447-55. PubMed ID: 21782812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Vaccine-Induced Extrafollicular Pathway of B Cell Differentiation Improves Rabies Postexposure Prophylaxis.
    Haley SL; Tzvetkov EP; Meuwissen S; Plummer JR; McGettigan JP
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS/Epac1-mediated Rap1/NF-kappaB activation is required for the expression of BAFF in Raw264.7 murine macrophages.
    Moon EY; Lee JH; Lee JW; Song JH; Pyo S
    Cell Signal; 2011 Sep; 23(9):1479-88. PubMed ID: 21596132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triptolide induces mitochondria-mediated apoptosis of Burkitt's lymphoma cell via deacetylation of GSK-3β by increased SIRT3 expression.
    Kong J; Wang L; Ren L; Yan Y; Cheng Y; Huang Z; Shen F
    Toxicol Appl Pharmacol; 2018 Mar; 342():1-13. PubMed ID: 29407771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.